European Investment Bank

Activity from announced rounds

Activity in this selectionBiotech

The European Investment Bank, abbreviated EIB, is the bank named in Reactive Technologies and Tensive financing announcements.

Recorded funding activity

Reactive measures electricity-grid inertia and stability in real time. Other recorded activity includes Morphotonics’ optical-component manufacturing equipment and HighLife’s transcatheter heart-valve technology. The bank remains distinct from the European Investment Fund and other institutions.

Sources
Rounds participated in
2
Confirmed lead rounds
0
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
—
0 disclosed · full round size, not this investor’s share

By stage

Series C+1
Undisclosed1

By primary sector

Biotech1
Healthtech1

By country

Italy1
Switzerland1

Rounds

2 in this selection
Nouscom

Clinical-stage biotech developing neoantigen-based cancer immunotherapies.

€120MSeries D
Participant
Tensive

Clinical-stage bioresorbable implants designed to support natural breast-tissue regeneration and mark the tumour bed after lumpectomy.

≤€20MConvertible venture debt
Participant